Clinical trial
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00235911 |
|---|---|
| Title | Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting |
| Official title | Effects of Symbicort Single Inhaler Therapy on Bronchial Hyper Responsiveness, Asthma Control and Safety in Mild to Moderate Asthmatics in General Practice, Compared to Usual Care Therapy |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | budesonide/formoterol Turbuhaler |
| Enrollment | 100 |
| Start date | Sep 1, 2003 |
| Primary completion | Oct 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Oct 12, 2005 |
| Last update posted | Jan 24, 2011 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: